Jes Olesen Selected Research

Migraine with Aura (Familial Hemiplegic Migraine)

1/2018	Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks.
12/2017	Family studies to find rare high risk variants in migraine.
3/2016	Migraine induced by hypoxia: an MRI spectroscopy and angiography study.
8/2015	Field-testing of the ICHD-3 beta/proposed ICD-11 diagnostic criteria for migraine with aura.
6/2011	Emerging migraine treatments and drug targets.
4/2011	Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine.
10/2010	Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.
9/2010	On the methodology of drug trials in migraine with aura.
2/2010	Coexisting typical migraine in familial hemiplegic migraine.
8/2009	Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jes Olesen Research Topics

Disease

118	Migraine Disorders (Migraine) 11/2022 - 01/2003
68	Headache (Headaches) 01/2022 - 09/2002
26	Pain (Aches) 01/2022 - 01/2003
13	Migraine without Aura (Common Migraine) 01/2020 - 01/2003
12	Migraine with Aura (Familial Hemiplegic Migraine) 01/2018 - 03/2006
9	Hypersensitivity (Allergy) 01/2022 - 09/2008
9	Epilepsy (Aura) 01/2020 - 09/2008
4	Hypoxia (Hypoxemia) 01/2019 - 12/2014
3	Tension-Type Headache (Tension Headache) 01/2021 - 11/2008
3	Photophobia (Light Sensitivity) 01/2018 - 03/2004
3	Headache Disorders (Headache Syndromes) 01/2018 - 03/2006
3	Cluster Headache (Cluster Headaches) 11/2016 - 11/2008
2	Constipation 05/2022 - 01/2020
2	Hyperalgesia 01/2021 - 01/2020
2	Trigeminal Neuralgia (Tic Douloureux) 01/2019 - 02/2015
2	Infarction (Infarctions) 07/2018 - 01/2018
2	Ischemia 07/2018 - 01/2018
2	Inflammation (Inflammations) 12/2015 - 11/2011
2	Nausea 11/2014 - 03/2004
2	Neurogenic Inflammation 06/2013 - 08/2010
2	Prescription Drug Overuse 04/2012 - 06/2006
2	Acute Pain 08/2010 - 06/2005
2	Myalgia 06/2005 - 01/2003
2	Intracranial Vasospasm 12/2004 - 04/2004
1	Primary Headache Disorders 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2020

Drug/Important Bio-Agent (IBA)

30	Pharmaceutical PreparationsIBA 01/2022 - 06/2006
29	Calcitonin Gene-Related PeptideIBA 01/2022 - 03/2004
17	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 11/2008
17	Sumatriptan (Imigran)FDA LinkGeneric 01/2021 - 04/2011
16	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021 - 03/2004
15	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2022 - 01/2009
15	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2003
13	Tryptamines (Triptans)IBA 01/2022 - 10/2006
12	ProstaglandinsIBA 12/2021 - 01/2003
9	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 12/2004
9	olcegepantIBA 01/2021 - 11/2004
9	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2019 - 01/2011
7	KATP ChannelsIBA 01/2022 - 01/2019
7	Cromakalim (Levcromakalim)IBA 01/2022 - 01/2019
7	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2003
7	Vasodilator Agents (Vasodilators)IBA 01/2018 - 09/2008
6	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 05/2022 - 11/2004
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2005
5	Messenger RNA (mRNA)IBA 01/2022 - 11/2010
5	Biological ProductsIBA 11/2021 - 10/2012
5	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2007
5	NeuropeptidesIBA 12/2017 - 09/2008
5	Dinoprostone (PGE2)FDA Link 02/2017 - 09/2010
5	Prostaglandins EIBA 08/2012 - 01/2003
4	Histamine (Histamine Dihydrochloride)FDA Link 03/2019 - 01/2003
4	Peptides (Polypeptides)IBA 01/2019 - 01/2011
4	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 02/2017 - 01/2011
4	Serotonin (5 Hydroxytryptamine)IBA 04/2012 - 01/2003
3	AntibodiesIBA 05/2022 - 12/2019
3	Monoclonal AntibodiesIBA 05/2022 - 04/2018
3	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 01/2022 - 08/2008
3	Pain-FreeIBA 01/2021 - 03/2004
3	Analgesics (Analgesic Drugs)IBA 12/2019 - 10/2010
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 03/2016
3	Carbon MonoxideIBA 11/2018 - 12/2014
3	Pemetrexed (MTA)FDA Link 01/2018 - 03/2006
3	Phosphodiesterase 3 InhibitorsIBA 11/2014 - 04/2004
3	Type A Botulinum Toxins (Botox)FDA Link 02/2012 - 11/2010
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2011 - 09/2008
3	telcagepantIBA 04/2011 - 12/2009
3	EnzymesIBA 11/2010 - 10/2003
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 07/2009 - 04/2004
3	Sildenafil Citrate (Viagra)FDA Link 10/2005 - 09/2002
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2005 - 09/2002
2	5-HT1F Serotonin ReceptorIBA 01/2022 - 06/2012
2	TRPA1 Cation ChannelIBA 12/2021 - 10/2020
2	AnkyrinsIBA 10/2020 - 08/2019
2	PotassiumIBA 01/2020 - 10/2019
2	Histamine Antagonists (Antihistamines)IBA 03/2019 - 01/2019
2	Retinaldehyde (Retinal)IBA 07/2018 - 01/2018
2	Glutamic Acid (Glutamate)FDA Link 03/2016 - 06/2005
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2014 - 01/2003
2	Cyclic AMP (AMP, Cyclic)IBA 11/2014 - 04/2004
2	Topiramate (Topamax)FDA LinkGeneric 05/2012 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 11/2010
2	tonabersatIBA 06/2011 - 08/2009
2	ProdrugsIBA 04/2010 - 11/2008
2	Phosphates (Orthophosphate)IBA 04/2010 - 01/2003
2	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 11/2008 - 10/2003
2	Ion Channels (Ion Channel)IBA 11/2008 - 08/2006
2	Adenosine (Adenocard)FDA LinkGeneric 09/2008 - 01/2003
2	BradykininIBA 06/2005 - 01/2003
1	ElementsIBA 11/2022
1	SolutionsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Serotonin ReceptorsIBA 10/2020
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 10/2020
1	Oxytocin Receptors (Oxytocin Receptor)IBA 10/2020
1	Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)IBA 10/2020

Therapy/Procedure

8	Intravenous Infusions 02/2017 - 10/2010
6	Therapeutics 01/2021 - 02/2012
5	Aftercare (After-Treatment) 01/2021 - 04/2011
2	Precision Medicine 12/2019 - 04/2019
2	Microvascular Decompression Surgery 01/2019 - 02/2015